General Information
Dr. Stamatia Pouliliou is a biologist at the National Public Health Organization (NPHO), with more than 12 years of laboratory experience at the Radiation Oncology Laboratory and the Medical Genetics Laboratory of the School of Medicine, Democritus University of Thrace (DUTH), Alexandroupolis, Greece. She holds a BSc in Biology (University of Patras, 2008), an MSc in Clinical Pharmacology and Therapeutics (DUTH, 2011), and a PhD in Radiotherapy and Oncology (DUTH, 2014). Her doctoral research focused on developing evaluation methods for detecting DNA damage in peripheral PBMCs after in vivo irradiation of patients undergoing radiotherapy—work that opened new directions for predicting early radiation toxicity. She has participated as a postdoctoral researcher in two Greek national projects (Metaboli-CA and TALK), sserved as a study coordinator in a multicenter, randomized clinical study (LPS14584, Sanofi), and acted as a pilot leader in the EU FP7 CARRE project. Additionally, she has received two IKY (State Scholarships Foundation) fellowships for her postdoctoral research on glioblastoma radiosensitization and tumor microenvironment–immune interactions in breast cancer.
Dr. Pouliliou has 35 peer-reviewed publications (h-index: 21, i10-index: 32) and 25 conference contributions. Her interdisciplinary expertise spans genetics, radiation biology, and cancer research, supported by strong skills in molecular, cellular, and biochemical techniques, research planning, and scientific problem-solving.
She also teaches undergraduate and postgraduate courses at the Democritus University of Thrace, and supervises undergraduate and postgraduate students. The full list of courses is provided here.